Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Accounts Payables (2016 - 2024)

Historic Accounts Payables for HUTCHMED (China) (HCM) over the last 11 years, with Q2 2025 value amounting to $43.7 million.

  • HUTCHMED (China)'s Accounts Payables rose 75.35% to $43.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $43.7 million, marking a year-over-year increase of 75.35%. This contributed to the annual value of $6.2 million for FY2024, which is 11903.39% up from last year.
  • Latest data reveals that HUTCHMED (China) reported Accounts Payables of $43.7 million as of Q2 2025, which was up 75.35% from $5.5 billion recorded in Q4 2024.
  • Over the past 5 years, HUTCHMED (China)'s Accounts Payables peaked at $5.5 billion during Q4 2024, and registered a low of -$3.0 million during Q1 2021.
  • For the 5-year period, HUTCHMED (China)'s Accounts Payables averaged around $1.0 billion, with its median value being $43.6 million (2024).
  • In the last 5 years, HUTCHMED (China)'s Accounts Payables tumbled by 15677.31% in 2021 and then soared by 5103892.97% in 2023.
  • Over the past 5 years, HUTCHMED (China)'s Accounts Payables (Quarter) stood at $9.6 million in 2021, then decreased by 4.95% to $9.1 million in 2022, then soared by 51038.93% to $4.6 billion in 2023, then increased by 17.65% to $5.5 billion in 2024, then tumbled by 99.2% to $43.7 million in 2025.
  • Its Accounts Payables was $43.7 million in Q2 2025, compared to $5.5 billion in Q4 2024 and $43.4 million in Q2 2024.